Is testosterone the new drug of choice on Wall Street? How traders are using male hormone booster shots to maintain a competitive edge

Is testosterone the new drug of choice on Wall Street How traders are using male hormone booster shots to maintain a competitive edge

The male hormone testosterone has become an unlikely drug of choice for Wall Street traders seeking to give themselves an edge over their professional rivals.

New York clinics have reported a rise in treatment for 'testosterone deficiency', sometimes known as 'andropause'.

They say many workers in the male-dominated industry are hoping that boosters of the hormone will help them perform better at work and put in longer hours.

Testosterone deficiency

Under pressure: New York clinics have reported a rise in demand for treatment for testosterone deficiency from Wall Street high-flyers

Upper West Side osteopath Lionel Bissoon, who now specialises in 'integrative medicine', says he first noticed demand for testosterone replacement therapy when the financial crisis hit.

He told the Financial Times: 'Since the recession started, more guys want to be on top of their game.'

Dr Lionel Bissoon

High demand: New York doctor Lionel Bissoon says 90 per cent of his patients work in finance

Ninety per cent of his patients, he revealed, hold senior positions in the finance industry and are typically in their thirties or forties.

'All of these men are under tons of stress, and stress will reduce
their levels of testosterone,' he said.

'As one patient told me: “There’s a whole
bunch of whizz-kids beneath me who are ready to take my place.”'

One patient, a 40-year-old venture capitalist who goes only by the name John, told the paper that his lack of drive and lethargy was initially diagnosed as depression. A consultation with Dr Bissoon, however, revealed that his problem was actually a testosterone deficiency.

John says: 'Wall
Street is a play hard, work hard environment. I now have a
bit more of an alpha male personality, and I’m able to get by on less

'It's the positive side of aggression. You change your mentality
and start looking positively at the future.'


The male hormone testosterone is produced by the testicles.

Hypogonadism is the medical term for a deficiency, and symptoms may include low libido, fatigue, muscle-loss and hair-loss.

Many other indications, such as poor sleep, depression and difficulty concentrating are more vague, and making it relatively difficult to diagnose, according to the Journal of Clinical Endocrinology and Metabolism.

Testosterone replacement therapy (TRT) can be administered through the skin, as a patch or gel, or as an injection.

It is no longer prescribed orally in the U.S. because the hormone was rendered inactive by the liver. It was also found to cause liver damage.

TRT is considered controversial because some physicians believe too much of the hormone poses an increased risk of prostate cancer in some patients.

Dr Bissoon added: 'If you’re going to be trading on Wall Street or dealing with large
sums of money, you had better be confident. The man who is
wishy-washy is not going to be successful.'

He is not the first to cash in on
this new demand. A company called Cenegenics, which has long offered
male hormone treatment at its 20 clinics around the U.S., is to open an
outpost near Wall Street next month.

But those who choose to have the treatment will need a Wall Street salary to afford it.

Initial fees can be around $4,000 as patients are given thorough tests – prior to treatment – that will alert doctors to risk factors like heart disease and a variety of different cancers.

Such tests would also reveal if a man had too-high levels of the female hormone oestrogen, one of the reasons they might be suffering from andropause symptoms like low energy, drive, concentration levels and libido.

Dr Bissoon says he is even treating some
women for testosterone deficiency, though, he admits, they are given
far lower doses in order to prevent the onset of typically masculine
traits like excess facial hair.